Wade G W & Inc Bristol Myers Squibb CO Transaction History

Wade G W & Inc

$3.08 Billion
Q4 2023

A detailed history of Wade G W & Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wade G W & Inc holds 31,409 shares of BMY stock, worth $1.78 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

31,409

Previous 32,766 4.14%

Holding current value

$1.78 Million

Previous $1.9 Million 15.25%

% of portfolio

0.05%

Previous 0.07%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$48.48 - $57.85 $65,787 - $78,502	-1,357 Reduced 4.14%	31,409 $1.61 Million
Q3 2023 Nov 08, 2023	BUY	$57.89 - $64.73 $90,018 - $100,655	1,555 Added 4.98%	32,766 $1.9 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $56,001 - $62,180	879 Added 2.9%	31,211 $2 Million
Q1 2023 May 09, 2023	SELL	$65.71 - $74.53 $54,605 - $61,934	-831 Reduced 2.67%	30,332 $2.1 Million
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $2,465 - $2,919	36 Added 0.12%	31,163 $2.24 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $91 - $53,941	702 Added 2.31%	31,127 $2.21 Million
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $78,574 - $86,538	1,082 Added 3.69%	30,425 $2.34 Million
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $80,046 - $95,983	1,302 Added 4.64%	29,343 $2.14 Million
Q4 2021 Feb 09, 2022	BUY	$53.63 - $62.52 $50,358 - $58,706	939 Added 3.46%	28,041 $1.75 Million
Q3 2021 Nov 03, 2021	BUY	$59.17 - $69.31 $9,881 - $11,574	167 Added 0.62%	27,102 $1.6 Million
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $21,792 - $23,731	-352 Reduced 1.29%	26,935 $1.8 Million
Q1 2021 May 05, 2021	BUY	$59.34 - $66.74 $204,960 - $230,519	3,454 Added 14.49%	27,287 $1.72 Million
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $330,734 - $374,783	5,728 Added 31.64%	23,833 $1.48 Million
Q3 2020 Nov 09, 2020	SELL	$57.43 - $63.64 $15,563 - $17,246	-271 Reduced 1.47%	18,105 $1.09 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $1,206 - $1,409	22 Added 0.12%	18,376 $1.08 Million
Q1 2020 May 06, 2020	SELL	$46.4 - $67.43 $17,121 - $24,881	-369 Reduced 1.97%	18,354 $1.02 Million
Q4 2019 Feb 07, 2020	SELL	$49.21 - $64.19 $31,248 - $40,760	-635 Reduced 3.28%	18,723 $1.2 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $8,938 - $10,598	-209 Reduced 1.07%	19,358 $982,000
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $2,007 - $2,220	45 Added 0.23%	19,567 $887,000
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $79,275 - $94,526	-1,757 Reduced 8.26%	19,522 $931,000
Q4 2018 Feb 04, 2019	BUY	$48.76 - $63.23 $45,346 - $58,803	930 Added 4.57%	21,279 $1.11 Million
Q3 2018 Nov 07, 2018	SELL	$55.19 - $62.25 $62,916 - $70,965	-1,140 Reduced 5.31%	20,349 $1.26 Million
Q1 2018 May 04, 2018	SELL	$59.92 - $68.98 $5,932 - $6,829	-99 Reduced 0.46%	21,489 $1.36 Million
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $2,037 - $2,221	34 Added 0.16%	21,588 $1.32 Million
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $1.19 Million - $1.37 Million	21,554	21,554 $1.37 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wade G W & Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wade G W & Inc with notifications on news.

Account